ロード中...
The Basic Research of the Combinatorial Therapy of ABT-199 and Homoharringtonine on Acute Myeloid Leukemia
BACKGROUND: Existing research shows that ABT-199, as a first-line drug, have been widely used in hematological malignancies, especially in leukemia, but the clinical efficacy of single drug therapy was limited part of the reason was that BCL-2 inhibitors failure to target other anti-apoptotic BCL-2...
保存先:
| 出版年: | Front Oncol |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8317985/ https://ncbi.nlm.nih.gov/pubmed/34336680 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2021.692497 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|